Titan Pharmaceuticals Inc (NAS:TTNP)
$ 6.34 -0.1409 (-2.17%) Market Cap: 5.80 Mil Enterprise Value: -398,000.00 PE Ratio: 0 PB Ratio: 0.75 GF Score: 38/100

Q2 2019 Titan Pharmaceuticals Inc Earnings Call Transcript

Aug 14, 2019 / 08:30PM GMT
Release Date Price: $420 (-4.24%)
Operator

Thank you for holding, and welcome to the Titan Pharmaceuticals Second Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please be advised that this call is being taped at the company's request and will be archived on the company's website starting later today.

At this time, I would like to turn the call over to Sunil Bhonsle, President and CEO of Titan Pharmaceuticals. Please go ahead, sir.

Sunil Bhonsle
Titan Pharmaceuticals, Inc. - President, CEO, Principal Financial Officer & Director

Thank you, Keith, and thank you all for joining us. Welcome to the Titan Pharmaceutical's call to review financial and operational results for the second quarter ending June 30, 2019, and to provide an update on our business.

Before we begin, I wanted to inform you that we filed our quarterly report on Form 10-Q with the SEC and the press release issued earlier today provides a summary of the results and can be found on our website at titanpharma.com.

Joining me on the call today from Titan are Dr. Marc Rubin, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot